Editorial: Genomics, proteomics and immunological signatures as diagnostic, predictive, and prognostic biomarkers in head and neck cancers
<p dir="ltr">Head and Neck Cancer (HNC) is the sixth most common cancer type accounting for approximately 900,000 cases and over 400,000 deaths annually. Heterogeneous malignancies involving the oral nasal cavities, paranasal sinuses, pharynx, larynx, and salivary glands are associat...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , |
| Published: |
2023
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1864513507697885184 |
|---|---|
| author | Afsheen Raza (492657) |
| author2 | Mehdi Bourouba (377477) Said Dermime (79420) |
| author2_role | author author |
| author_facet | Afsheen Raza (492657) Mehdi Bourouba (377477) Said Dermime (79420) |
| author_role | author |
| dc.creator.none.fl_str_mv | Afsheen Raza (492657) Mehdi Bourouba (377477) Said Dermime (79420) |
| dc.date.none.fl_str_mv | 2023-01-25T09:00:00Z |
| dc.identifier.none.fl_str_mv | 10.3389/fimmu.2023.1122736 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Editorial_Genomics_proteomics_and_immunological_signatures_as_diagnostic_predictive_and_prognostic_biomarkers_in_head_and_neck_cancers/26772166 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Clinical sciences Immunology Oncology and carcinogenesis head and neck cancers nasopharyngeal carcinoma proteomics signature genomics/molecular markers immunological markers cytokines soluble mediators |
| dc.title.none.fl_str_mv | Editorial: Genomics, proteomics and immunological signatures as diagnostic, predictive, and prognostic biomarkers in head and neck cancers |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p dir="ltr">Head and Neck Cancer (HNC) is the sixth most common cancer type accounting for approximately 900,000 cases and over 400,000 deaths annually. Heterogeneous malignancies involving the oral nasal cavities, paranasal sinuses, pharynx, larynx, and salivary glands are associated with HNC. The 5-year survival rate for HNC is 64% with median overall survival length ranging from 1.4 to 8.7 years, with glottic larynx cancer having the longest and hypopharynx cancer the shortest. The risk factors most frequently associated with head and neck cancer include smoking, alcohol consumption, diet, human papillomavirus (HPV) and Epstein-Barr virus (EBV) infections. The North African and South-East Asian populations are the most affected by these types of cancers. Recent estimates predict a major increase from 45%-77%, in the number of people who will be affected by these types of tumors in the next 20 years.</p><h2>Other Information</h2><p dir="ltr">Published in: Frontiers in Immunology<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3389/fimmu.2023.1122736" target="_blank">https://dx.doi.org/10.3389/fimmu.2023.1122736</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_8ecc0f09170c52e9033fa48451e504e4 |
| identifier_str_mv | 10.3389/fimmu.2023.1122736 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/26772166 |
| publishDate | 2023 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Editorial: Genomics, proteomics and immunological signatures as diagnostic, predictive, and prognostic biomarkers in head and neck cancersAfsheen Raza (492657)Mehdi Bourouba (377477)Said Dermime (79420)Biomedical and clinical sciencesClinical sciencesImmunologyOncology and carcinogenesishead and neck cancersnasopharyngeal carcinomaproteomics signaturegenomics/molecular markersimmunological markerscytokinessoluble mediators<p dir="ltr">Head and Neck Cancer (HNC) is the sixth most common cancer type accounting for approximately 900,000 cases and over 400,000 deaths annually. Heterogeneous malignancies involving the oral nasal cavities, paranasal sinuses, pharynx, larynx, and salivary glands are associated with HNC. The 5-year survival rate for HNC is 64% with median overall survival length ranging from 1.4 to 8.7 years, with glottic larynx cancer having the longest and hypopharynx cancer the shortest. The risk factors most frequently associated with head and neck cancer include smoking, alcohol consumption, diet, human papillomavirus (HPV) and Epstein-Barr virus (EBV) infections. The North African and South-East Asian populations are the most affected by these types of cancers. Recent estimates predict a major increase from 45%-77%, in the number of people who will be affected by these types of tumors in the next 20 years.</p><h2>Other Information</h2><p dir="ltr">Published in: Frontiers in Immunology<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3389/fimmu.2023.1122736" target="_blank">https://dx.doi.org/10.3389/fimmu.2023.1122736</a></p>2023-01-25T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3389/fimmu.2023.1122736https://figshare.com/articles/journal_contribution/Editorial_Genomics_proteomics_and_immunological_signatures_as_diagnostic_predictive_and_prognostic_biomarkers_in_head_and_neck_cancers/26772166CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/267721662023-01-25T09:00:00Z |
| spellingShingle | Editorial: Genomics, proteomics and immunological signatures as diagnostic, predictive, and prognostic biomarkers in head and neck cancers Afsheen Raza (492657) Biomedical and clinical sciences Clinical sciences Immunology Oncology and carcinogenesis head and neck cancers nasopharyngeal carcinoma proteomics signature genomics/molecular markers immunological markers cytokines soluble mediators |
| status_str | publishedVersion |
| title | Editorial: Genomics, proteomics and immunological signatures as diagnostic, predictive, and prognostic biomarkers in head and neck cancers |
| title_full | Editorial: Genomics, proteomics and immunological signatures as diagnostic, predictive, and prognostic biomarkers in head and neck cancers |
| title_fullStr | Editorial: Genomics, proteomics and immunological signatures as diagnostic, predictive, and prognostic biomarkers in head and neck cancers |
| title_full_unstemmed | Editorial: Genomics, proteomics and immunological signatures as diagnostic, predictive, and prognostic biomarkers in head and neck cancers |
| title_short | Editorial: Genomics, proteomics and immunological signatures as diagnostic, predictive, and prognostic biomarkers in head and neck cancers |
| title_sort | Editorial: Genomics, proteomics and immunological signatures as diagnostic, predictive, and prognostic biomarkers in head and neck cancers |
| topic | Biomedical and clinical sciences Clinical sciences Immunology Oncology and carcinogenesis head and neck cancers nasopharyngeal carcinoma proteomics signature genomics/molecular markers immunological markers cytokines soluble mediators |